Metoprolol for the Treatment of Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells
Conditions: Solid Tumor; Hematologial Malignancy Intervention: Drug: Metoprolol Sponsor: Chinese PLA General Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2019 Category: Research Source Type: clinical trials